Aquilion ONE (TSX-306A/3) V10.4 with Spectral Imaging System

The Aquilion ONE (TSX-306A/3) V10.4 with Spectral Imaging System is a computed tomography device designed for whole-body imaging, including single-rotation organ scans, with a significant update being the extension of its spectral capabilities to cardiac applications. It utilizes rapid kV switching for dual-energy data acquisition, along with iterative (FIRST) and deep learning-based (AiCE) reconstruction techniques to enhance image quality, reduce noise, and provide detailed material differentiation from X-ray attenuation, aiming for optimized contrast media use.

The Aquilion ONE (TSX-306A/3) V10.4 with Spectral Imaging System is an advanced whole-body multi-slice helical CT scanner designed to acquire and display cross-sectional volumetric data for a wide range of anatomical regions, including the head, and capable of imaging entire organs like the brain, heart, and pancreas in a single rotation. This system incorporates several key technologies: the FIRST iterative reconstruction algorithm aims to reduce radiation exposure dose while enhancing high-contrast spatial resolution for various applications; additionally, the AiCE algorithm, utilizing Deep Convolutional Neural Network methods, works to improve image quality by reducing noise across multiple anatomical areas, including cardiac and brain imaging; the core Spectral Imaging System enables the acquisition of two nearly simultaneous CT images using distinct tube voltages and/or currents via rapid KV switching, allowing for differentiation of material compositions based on X-ray attenuation differences. This version (V10.4) introduces significant enhancements, primarily extending the Spectral Imaging System's capabilities to include cardiac applications and improving overall image quality for existing spectral scan regions. New features within the spectral workflow include Metal Artifact Reduction (MAR), ECG-gated scanning, gantry tilt functionality, and a faster gantry rotation time of 0.275 seconds. Bench testing demonstrated notable performance improvements: Spectral 70keV imaging was found to be dose-neutral compared to single-energy 120kVp imaging, achieved a 50% noise reduction, yielded a 150% improvement in Contrast-to-Noise Ratio (CNR) for iodine, and allowed for a 60% reduction in iodine concentration at 60keV relative to single-energy scans. Clinical images for abdomen/pelvis, lung, extremity, and the newly added cardiac region were confirmed to be of diagnostic quality, and the system also supports optimization of iodinated contrast media usage within approved dosing guidelines.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the "rapid KV switching" technology in the Spectral Imaging System specifically impact the temporal resolution for dynamic studies, especially in the newly added cardiac applications?; What are the quantitative differences in image quality (e.g., CNR, spatial resolution) and diagnostic performance between images processed with the FIRST algorithm versus the AiCE Deep Convolutional Neural Network algorithm for similar anatomical regions and patient populations?; Beyond the reported 60% iodine concentration reduction at 60keV, what is the optimal energy level for maximizing iodine conspicuity while minimizing dose across different patient body habitus for the Spectral Imaging System?; How does the new Metal Artifact Reduction (MAR) feature in the spectral workflow compare in efficacy to existing MAR techniques in conventional CT, particularly in challenging anatomical areas with large metallic implants?; What are the specific mechanisms by which the image quality improvements for "existing Spectral scan regions" were achieved in V10.4, and how do these translate to tangible clinical benefits beyond what was available in V10.0?